Drug intelligence / Profile preview

multiprofen-cc

Development stage
Phase 3
Lead developer
KAZM Pharmaceuticals
Modality
Hydrogel Systems → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

Multiprofen-CC is a multimodal topical cream formulated for the management of localized musculoskeletal pain, particularly in patients undergoing procedures such as total knee arthroplasty. It contains four active pharmaceutical ingredients: ketoprofen (10%), a non-steroidal anti-inflammatory drug (NSAID) that inhibits prostaglandin synthesis; baclofen (5%), a GABA-B receptor agonist and muscle relaxant; amitriptyline (2%), a tricyclic antidepressant with analgesic properties likely mediated by inhibition of norepinephrine and serotonin reuptake; and lidocaine (5%), a local anesthetic that blocks sodium channels to prevent nerve depolarization. The combination targets multiple pain pathways, aiming to provide enhanced analgesia while potentially reducing opioid requirements post-surgery. Multiprofen-CC is compounded for individual patients rather than mass-produced, with each ingredient approved by Health Canada[1][2][3][4][5].

Brand names
Multiprofen-CC
Other names
Multiprofen-CC
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)GABA-B (Gamma-aminobutyric acid receptor type B)SERT (Sodium-dependent serotonin transporter)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)SCN9A (Sodium channel protein type 9 subunit alpha)NET (Norepinephrine Transporter)

Beyond the preview

Go deeper on multiprofen-cc.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on multiprofen-cc.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call